QRL-101 is under clinical development by QurAlis and currently in Phase I for Epilepsy. According to GlobalData, Phase I drugs for Epilepsy have an 84% phase transition success rate (PTSR) indication ...

Topiramate is under development for the treatment of obesity, epilepsy and migrane. The drug candidate is administered intravenously, oral and intramuscularly. It is developed using an advanced drug ...

Company Coverage includes Jazz Pharmaceuticals, UCB, Takeda Pharmaceutical, Biocodex, Longboard Pharmaceuticals, Stoke Therapeutics, Thermo Fisher Scientific, Harmony Biosciences Holdings, Ovid ...

Wish granted meaning Breakthrough in Alzheimer's disease imaging diagnosis: FDA approves first tau pathology imaging drug Breakthrough: New vitamin ...

UK Medical Eligibility Criteria for Contraceptive Use Category 1: A condition for which there is no restriction for the use of the contraceptive method with the condition or in that circumstance.

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

After hours: December 27 at 6:39:18 PM EST Loading Chart for DRUG ...

INR:1564. bet365 apps download Nature's big news! These latest studies are expected to bring innovative treatments to the autism community The most comprehen ...

Praxis Precision Medicines, Inc., a promising clinical stage biopharma concern, has seen significant stock gains in the ...

Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...